Want to see GB:RTO full AI Analyst Report?
Rentokil Initial (RTO) AI Stock Analysis
Rentokil Initial
(LSE:RTO)
The score is supported primarily by solid financial performance (growth and cash generation, with improving leverage) and a constructive earnings update that reaffirmed guidance and showed strong cash conversion. The main drag is weak technicals, with the stock trading below key moving averages and bearish momentum. Valuation is neither clearly cheap nor prohibitive, but the modest yield and ~25x P/E keep it from scoring higher.
Rentokil Initial (RTO) vs. iShares MSCI United Kingdom ETF (EWC)
- Market Cap
- GBP 8.81B
- Dividend Yield
- 2.68%
- Average Volume (3M)
- 11.52M
- Price to Earnings (P/E)
- 24.8
- Beta (1Y)
- 0.82
- Revenue Growth
- -0.18%
- EPS Growth
- 39.04%
- Country
- UK
- Employees
- 63,388
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Specialty Business Services
Rentokil Initial Business Overview & Revenue Model
Company Description
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, Europe, the United Kingdom, Asia, the Middle East, North Africa, Turkey, and Pacific. The company offers a range of pest control services for rodent...
How the Company Makes Money
Rentokil Initial makes money mainly by selling recurring, contract-based services delivered on a scheduled route network, supplemented by one-off jobs and product-related sales tied to those services. The largest revenue stream is pest control: custo...
Rentokil Initial Earnings Call Summary
The call presented solid financial progress — revenue and operating profit growth, strong cash conversion (96%) and reduced leverage (2.4x) — and clear operational achievements (transformation savings, branch rollout, improved residential performance and regional brand momentum). However, there are meaningful near-term challenges: slower commercial performance, a late-Q2 weakness in residential (termite) leads, higher central costs, increased legacy-termite provisions and elevated one-off transformation cash costs. Management has a detailed remediation plan (sales and operational excellence, customer focus, simplification) and expects steady progress with some initiatives potentially taking up to two years. Overall, the positives on profitability, cash generation and early transformation wins outweigh the stated headwinds, but execution risk on commercial recovery and simplification remains material.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management reiterated that full‑year profit is expected in line with market expectations and that the group remains on track for >80% cash conversion (H1 conversion 96%; FCF growth +12.8%), with H1 revenue up 4.5% to $3.589bn (organic +3.6%), operating profit $556m (+6.6%) and an operating margin of 15.5% (+30bps); EPS rose 8.3%. Balance sheet targets include leverage at 2.4x (down 0.4x YoY) now within the 2.0–2.5x target range, net debt down $75m and an interim dividend increase of 8%. The company raised its full‑year cash guidance for one‑off/adjusting items to $110–$120m (H1 cash impact $70m), increased expected cash outflow on the legacy termite provision to $115–$125m, reduced FY M&A spend guidance to $120m, and said central costs (H1 +16.9%) should moderate to low double‑digit growth. Regional detail: North America H1 revenue $2.197bn (+4.2%, organic +3.7%), operating profit $393m (+10.2%) margin 17.9% (+1ppt) (Pest Control margin ~20%, up 1.4% since 2024; residential leads +6%; Business Services +10.6%); transformation delivered $45m gross savings in H1 (net $28m) with ~ $90m annualized run‑rate. International H1 revenue $1.392bn (+5.0%, organic +3.5%), operating profit $266m (+4.3%) margin 19.1%; Q2 international pest organic +5.4% (ex certain businesses +5.8%). Overall, there is no change to the outlook.
Rentokil Initial Financial Statement Overview
Summary
Fundamentals are solid: strong multi-year revenue expansion and consistently positive free cash flow with improving cash generation. Balance sheet leverage has improved materially in the latest year, supporting financial flexibility. Offsetting factors include historical periods of higher leverage and some reported profitability/margin volatility that reduces consistency.
Income Statement
74PositiveBalance Sheet
66PositiveCash Flow
71Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.11B | 5.13B | 5.44B | 5.38B | 3.71B | 2.95B |
| Gross Profit | 4.41B | 4.26B | 4.56B | 1.50B | 977.00M | 714.80M |
| EBITDA | 1.24B | 1.13B | 1.10B | 1.15B | 747.00M | 640.49M |
| Net Income | 239.80M | 356.63M | 307.00M | 381.00M | 232.00M | 263.00M |
Balance Sheet | ||||||
| Total Assets | 10.97B | 10.73B | 10.55B | 11.13B | 11.92B | 4.32B |
| Cash, Cash Equivalents and Short-Term Investments | 1.86B | 1.73B | 911.00M | 1.56B | 2.09B | 597.90M |
| Total Debt | 4.59B | 4.56B | 4.11B | 4.73B | 5.40B | 1.93B |
| Total Liabilities | 6.81B | 6.65B | 6.33B | 7.04B | 7.82B | 3.06B |
| Stockholders Equity | 4.16B | 4.09B | 4.23B | 4.09B | 4.10B | 1.26B |
Cash Flow | ||||||
| Free Cash Flow | 568.69M | 583.51M | 463.00M | 526.00M | 410.00M | 403.30M |
| Operating Cash Flow | 686.08M | 741.34M | 678.00M | 737.00M | 600.00M | 563.20M |
| Investing Cash Flow | 83.08M | 15.93M | -373.00M | -416.00M | -1.20B | -441.10M |
| Financing Cash Flow | -441.56M | 20.49M | -752.00M | -361.00M | 1.32B | -417.10M |
Rentokil Initial Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:RTO, the sentiment is Neutral. The current price of 350.10 is above the 20-day moving average (MA) of 319.81, above the 50-day MA of 325.29, and below the 200-day MA of 414.56, indicating a neutral trend. The MACD of 7.35 indicates Negative momentum. The RSI at 74.78 is Negative, neither overbought nor oversold. The STOCH value of 90.43 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:RTO.
Rentokil Initial Risk Analysis
Rentokil Initial disclosed 27 risk factors in its most recent earnings report. Rentokil Initial reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksRentokil Initial Peers Comparison
Overall Rating
GB:ITRK73Outperform
GB:MTO67Neutral
GB:JSG64Neutral
GB:SRP62Neutral- GB:RTO62Neutral
GB:RST60Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| GB:ITRK | 73Outperform | GBP 9.10B | 28.51 | 29.86% | 2.78% | 3.94% | -8.14% |
| GB:MTO | 67Neutral | GBP 2.65B | 32.35 | 15.86% | 2.15% | 10.55% | -19.05% |
| GB:JSG | 64Neutral | GBP 500.98M | 14.84 | 13.74% | 3.49% | 1.73% | 9.66% |
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
| GB:SRP | 62Neutral | GBP 2.75B | 18.75 | 17.55% | 1.61% | 1.20% | 221.80% |
| GB:RTO | 62Neutral | GBP 8.80B | 24.81 | 5.82% | 2.68% | -0.18% | 39.04% |
| GB:RST | 60Neutral | GBP 405.76M | 146.21 | 1.30% | 2.37% | 8.11% | -69.68% |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GB:RTO | Rentokil Initial | 350.10 | -61.73 | -14.99% | |
| GB:ITRK | Intertek Group plc | 5930.00 | 988.42 | 20.00% | |
| GB:JSG | Johnson Service | 143.20 | 12.71 | 9.74% | |
| GB:MTO | Mitie Group plc | 209.00 | 50.47 | 31.84% | |
| GB:RST | Restore plc | 308.50 | 62.77 | 25.54% | |
| GB:SRP | Serco Group plc | 288.20 | 41.09 | 16.63% |
Rentokil Initial Corporate Events
Rentokil Initial Sells SOLitude Lake Management to Bain Capital for $230m
PositiveRentokil Initial has agreed to sell SOLitude Lake Management, LLC and its Vertex Aquatic Solutions division to Bain Capital for total consideration of $230m on a cash-free, debt-free basis, with estimated net cash proceeds of about $180m after tax. T...
Rentokil Initial Sets Sterling Value of Interim Dividend at 3.29p Per Share
PositiveRentokil Initial plc has confirmed the sterling amount of its previously announced interim dividend for the six months to 30 June 2026, converting the declared 4.48 cents per ordinary share into 3.29 pence per share. The conversion was based on the a...
Rentokil Initial Reshapes Global Structure With New Divisions and Transformation Chief
PositiveRentokil Initial is formalising its operating structure into two divisions, North America and International, covering Europe, the UK, Ireland and Sub-Saharan Africa, Asia and MENAT, Latin America and the Pacific. The move is designed to simplify the...
Rentokil Initial Executives and Directors Boost Holdings with Coordinated Share Purchases
PositiveRentokil Initial reported a series of insider share purchases by senior leadership and board members, including Chief Executive Mike Duffy, who acquired 10,500 American Depositary Shares in a joint account with a closely associated person, and the Th...
Rentokil Initial Sets Growth Platform as Interim Results Show Solid Progress
PositiveRentokil Initial reported solid interim performance for the six months to 30 June 2026, with revenue up 6.7%, organic revenue growth of 3.6% and adjusted operating profit rising 6.6%, supported by strong cash generation and a higher dividend. North A...
Rentokil Initial Senior Independent Director Joins SSE Board
PositiveRentokil Initial said its Senior Independent Director, John Pettigrew, has been appointed as a non-executive director to the board of SSE plc, effective 1 December 2026. The move broadens Pettigrew’s external board responsibilities and may enha...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 17, 2026